Impact of early therapeutic modality on 28-day mortality in immunocompromised patients with opportunistic pulmonary infections: a multicenter retrospective study
Therapeutic Advances in Respiratory Disease
Published online on June 24, 2026
Abstract
Therapeutic Advances in Respiratory Disease, Volume 20, January-December 2026.
Background:Opportunistic pulmonary infections remain a significant threat in immunocompromised cases.Objectives:This study aims to evaluate the impact of early therapeutic modalities on 28-day mortality in non-AIDS and non-solid tumor immunocompromised ...
Background:Opportunistic pulmonary infections remain a significant threat in immunocompromised cases.Objectives:This study aims to evaluate the impact of early therapeutic modalities on 28-day mortality in non-AIDS and non-solid tumor immunocompromised ...